274 related articles for article (PubMed ID: 35499042)
1.
Zhang H; Qi J; Pei J; Zhang M; Shang Y; Li Z; Wang Y; Guo J; Sun K; Fan J; Sui L; Xu Y; Kong L; Kong Y
J Adv Res; 2022 Mar; 37():119-131. PubMed ID: 35499042
[TBL] [Abstract][Full Text] [Related]
2. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
[No Abstract] [Full Text] [Related]
3. Posttranslational, reversible O-glycosylation is stimulated by high glucose and mediates plasminogen activator inhibitor-1 gene expression and Sp1 transcriptional activity in glomerular mesangial cells.
Goldberg HJ; Whiteside CI; Hart GW; Fantus IG
Endocrinology; 2006 Jan; 147(1):222-31. PubMed ID: 16365142
[TBL] [Abstract][Full Text] [Related]
4. First characterization of glucose flux through the hexosamine biosynthesis pathway (HBP) in
Olson AK; Bouchard B; Zhu WZ; Chatham JC; Des Rosiers C
J Biol Chem; 2020 Feb; 295(7):2018-2033. PubMed ID: 31915250
[TBL] [Abstract][Full Text] [Related]
5. O-Linked N-acetylglucosaminylation of Sp1 interferes with Sp1 activation of glycolytic genes.
Lim K; Yoon BH; Ha CH
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):349-53. PubMed ID: 26499076
[TBL] [Abstract][Full Text] [Related]
6. Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation.
Lucena MC; Carvalho-Cruz P; Donadio JL; Oliveira IA; de Queiroz RM; Marinho-Carvalho MM; Sola-Penna M; de Paula IF; Gondim KC; McComb ME; Costello CE; Whelan SA; Todeschini AR; Dias WB
J Biol Chem; 2016 Jun; 291(25):12917-29. PubMed ID: 27129262
[TBL] [Abstract][Full Text] [Related]
7. Single cell and bulk RNA expression analyses identify enhanced hexosamine biosynthetic pathway and O-GlcNAcylation in acute myeloid leukemia blasts and stem cells.
Schauner R; Cress J; Hong C; Wald D; Ramakrishnan P
Front Immunol; 2024; 15():1327405. PubMed ID: 38601153
[TBL] [Abstract][Full Text] [Related]
8. IDH2, a novel target of OGT, facilitates glucose uptake and cellular bioenergy production via NF-κB signaling to promote colorectal cancer progression.
He X; Wu N; Li R; Zhang H; Zhao Y; Nie Y; Wu J
Cell Oncol (Dordr); 2023 Feb; 46(1):145-164. PubMed ID: 36401762
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the impact of the hexosamine biosynthesis pathway and O-GlcNAcylation on glucose metabolism in bovine granulosa cells.
Maucieri AM; Townson DH
Mol Cell Endocrinol; 2023 Mar; 564():111863. PubMed ID: 36690170
[TBL] [Abstract][Full Text] [Related]
10. O-GlcNAcylation Enhances Double-Strand Break Repair, Promotes Cancer Cell Proliferation, and Prevents Therapy-Induced Senescence in Irradiated Tumors.
Efimova EV; Appelbe OK; Ricco N; Lee SS; Liu Y; Wolfgeher DJ; Collins TN; Flor AC; Ramamurthy A; Warrington S; Bindokas VP; Kron SJ
Mol Cancer Res; 2019 Jun; 17(6):1338-1350. PubMed ID: 30885991
[TBL] [Abstract][Full Text] [Related]
11. Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.
Ma Z; Vocadlo DJ; Vosseller K
J Biol Chem; 2013 May; 288(21):15121-30. PubMed ID: 23592772
[TBL] [Abstract][Full Text] [Related]
12. Hexosamines, insulin resistance, and the complications of diabetes: current status.
Buse MG
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E1-E8. PubMed ID: 16339923
[TBL] [Abstract][Full Text] [Related]
13. Bittersweet tumor development and progression: Emerging roles of epithelial plasticity glycosylations.
Phillips RM; Lam C; Wang H; Tran PT
Adv Cancer Res; 2019; 142():23-62. PubMed ID: 30885363
[TBL] [Abstract][Full Text] [Related]
14. New insights: A role for O-GlcNAcylation in diabetic complications.
Peterson SB; Hart GW
Crit Rev Biochem Mol Biol; 2016; 51(3):150-61. PubMed ID: 26806492
[TBL] [Abstract][Full Text] [Related]
15. Glucose sensing O-GlcNAcylation pathway regulates the nuclear bile acid receptor farnesoid X receptor (FXR).
Berrabah W; Aumercier P; Gheeraert C; Dehondt H; Bouchaert E; Alexandre J; Ploton M; Mazuy C; Caron S; Tailleux A; Eeckhoute J; Lefebvre T; Staels B; Lefebvre P
Hepatology; 2014 May; 59(5):2022-33. PubMed ID: 24037988
[TBL] [Abstract][Full Text] [Related]
16. Hexosamine Biosynthetic Pathway-Derived O-GlcNAcylation Is Critical for RANKL-Mediated Osteoclast Differentiation.
Kim MJ; Kim HS; Lee S; Min KY; Choi WS; You JS
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445596
[TBL] [Abstract][Full Text] [Related]
17. O-GlcNAcylation and O-GlcNAc Cycling Regulate Gene Transcription: Emerging Roles in Cancer.
Parker MP; Peterson KR; Slawson C
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33916244
[TBL] [Abstract][Full Text] [Related]
18. Foetal recapitulation of nutrient surplus signalling by O-GlcNAcylation and the failing heart.
Packer M
Eur J Heart Fail; 2023 Aug; 25(8):1199-1212. PubMed ID: 37434410
[TBL] [Abstract][Full Text] [Related]
19. O-GlcNAc Transferase Links Glucose Metabolism to MAVS-Mediated Antiviral Innate Immunity.
Li T; Li X; Attri KS; Liu C; Li L; Herring LE; Asara JM; Lei YL; Singh PK; Gao C; Wen H
Cell Host Microbe; 2018 Dec; 24(6):791-803.e6. PubMed ID: 30543776
[TBL] [Abstract][Full Text] [Related]
20. O-GlcNAcylation regulates cancer metabolism and survival stress signaling via regulation of the HIF-1 pathway.
Ferrer CM; Lynch TP; Sodi VL; Falcone JN; Schwab LP; Peacock DL; Vocadlo DJ; Seagroves TN; Reginato MJ
Mol Cell; 2014 Jun; 54(5):820-31. PubMed ID: 24857547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]